BOOTS UK LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries, Miscellaneous General Merchandise Stores, Drug Stores and Proprietary Stores), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about BOOTS UK LIMITED
Live alerts from global media, monitored by Business Radar
2024-08-21 (nasdaq.com)
Class Action Lawsuit Against Walgreens Boots Alliance (:WBA) |
A class action lawsuit was filed against Walgreens Boots Alliance (WBA) by Levi & Korsinsky on July 12, 2024. The plaintiffs (shareholders) alleged that they bought WBA stock at artificially inflated prices between October 12, 2023 and June 26, 2024 (Class Period) and are now seeking compensation for their financial losses. Investors who bought Walgreens Boots Alliance stock during that period can click here to learn about joining the lawsuit.Walgreens Boots operates a chain of retail pharmacy stores under the banner Walgreens in the U.S. and Boots in the UK. The overall healthcare industry is under pressure due to weak consumer sentiment and macroeconomic uncertainty. WBA is also facing margin pressures and declining net income, which resulted in a lowering of the full-year outlook in June. Walgreens Boots' Misleading ClaimsAccording to the lawsuit, WBA and three of its senior officers (Individual Defendants) repeatedly made false and misleading public statements throughout the Class Period. Particularly,
Read more